A detailed history of Apella Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Apella Capital, LLC holds 9,047 shares of MRK stock, worth $881,539. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,047
Previous 8,003 13.05%
Holding current value
$881,539
Previous $990,000 3.74%
% of portfolio
0.04%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$111.15 - $128.97 $116,040 - $134,644
1,044 Added 13.05%
9,047 $1.03 Million
Q2 2024

Jul 10, 2024

BUY
$123.8 - $132.96 $228,534 - $245,444
1,846 Added 29.98%
8,003 $990,000
Q1 2024

Apr 10, 2024

BUY
$113.24 - $131.95 $40,653 - $47,370
359 Added 6.19%
6,157 $812,000
Q4 2023

Jan 05, 2024

SELL
$100.18 - $109.02 $13,323 - $14,499
-133 Reduced 2.24%
5,798 $632,000
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $26,355 - $29,268
256 Added 4.51%
5,931 $610,000
Q2 2023

Jul 06, 2023

SELL
$108.61 - $118.38 $75,918 - $82,747
-699 Reduced 10.97%
5,675 $654,000
Q4 2022

Jan 10, 2023

BUY
$87.44 - $112.11 $149,085 - $191,147
1,705 Added 36.52%
6,374 $0
Q3 2022

Oct 11, 2022

BUY
$84.53 - $94.96 $20,878 - $23,455
247 Added 5.59%
4,669 $402,000
Q2 2022

Jul 08, 2022

BUY
$83.49 - $94.64 $7,597 - $8,612
91 Added 2.1%
4,422 $403,000
Q1 2022

Apr 11, 2022

BUY
$73.51 - $82.4 $6,174 - $6,921
84 Added 1.98%
4,331 $355,000
Q4 2021

Jan 13, 2022

SELL
$72.28 - $90.54 $50,596 - $63,378
-700 Reduced 14.15%
4,247 $325,000
Q3 2021

Jan 18, 2022

BUY
$71.68 - $78.83 $15,339 - $16,869
214 Added 4.52%
4,947 $372,000
Q3 2021

Oct 12, 2021

SELL
$71.68 - $78.83 $102,144 - $112,332
-1,425 Reduced 23.14%
4,733 $386,000
Q2 2021

Jan 18, 2022

BUY
$70.31 - $77.77 $22,499 - $24,886
320 Added 5.48%
6,158 $479,000
Q2 2021

Jul 02, 2021

SELL
$70.31 - $77.77 $76,637 - $84,769
-1,090 Reduced 15.73%
5,838 $454,000
Q1 2021

Apr 15, 2021

SELL
$68.86 - $81.11 $82,356 - $97,007
-1,196 Reduced 14.72%
6,928 $534,000
Q4 2020

Feb 18, 2021

SELL
$71.77 - $79.65 $23,755 - $26,364
-331 Reduced 3.91%
8,124 $665,000
Q3 2020

Oct 22, 2020

BUY
$73.18 - $82.95 $31,101 - $35,253
425 Added 5.29%
8,455 $701,000
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $508,780 - $705,194
8,030 New
8,030 $618,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Apella Capital, LLC Portfolio

Follow Apella Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.